Article contents
Commentary: Who's Afraid of the RAC? Lessons from the Oversight of Controversial Science
Published online by Cambridge University Press: 01 January 2021
Abstract
An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
- Type
- Symposium
- Information
- Copyright
- Copyright © American Society of Law, Medicine and Ethics 2009
References
Wolf, S. M., Gupta, R. and Kohlepp, P., “Gene Therapy Oversight: Lessons for Nanobiotechnology,” Journal of Law, Medicine & Ethics 37, no. 4 (2009): 659–684.CrossRefGoogle Scholar
Fredrickson, D. S., The Recombinant DNA Controversy (Washington, D.C.: American Society of Microbiology Press, 2001): at 278.CrossRefGoogle Scholar
Scott, C., “What Stem Cell Therapy Can Learn from Gene Therapy,” Nature Reports Stem Cells (2008), published online September 4, 2008.CrossRefGoogle Scholar
- 1
- Cited by